Original Article
Glycosylated hemoglobin and adverse events following elective coronary bypass revascularization
Author(s): Luca Koechlin, Ulrich Schurr, Brigitta Gahl, Martin Grapow, Oliver Reuthebuch and Denis A. Berdajs*
BACKGROUND: The aim of this retrospective study was to evaluate whether the level of preoperative glycosylated hemoglobin (HbA1c) is associated with incidence of major adverse events in patients undergoing elective coronary bypass surgery.
METHODS: This was a retrospective observational study of 1,116 patients undergoing elective, isolated aortocoronary bypass surgery over a period of 5 years. Two groups were investigated, one with a preoperative HbA1c level ≤6.5% and the other with HbA1c superior to 6.5%. We used propensity modelling to calculate inverse probability of treatment weights (IPTW) for quantifying the association of increased HbA1c on outcome.
RESULTS: According to inclusion criteria, 589 patients (mean age, 68.1 year.. Read More»
DOI:
10.4172/2368-0512.1000105
